CD133-EPITOPE
European patent · EP2427485 · In force
Register entry
- Publication number
- EP2427485
- Application number
- EP10772898
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 7, 2010
- Published
- Mar 14, 2012
- Granted
- Dec 7, 2016
- Protection ends at the latest
- May 6, 2030
- Next annual fee due
- May 31, 2027
- IPC classes
- C07K 14/705 (2006.01)A61K 38/17 (2006.01)A61K 39/00 (2006.01)A61K 9/127 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 176302 P 07.05.2009
- PCT application
- PCT/US2010/034082 07.05.2010
- PCT publication
- WO2010/129895 11.11.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 9, 2023
Change
Published in Swissreg on 09.06.2023
- Jul 6, 2017
Address changed
- Owner
- ImmunoCellular Therapeutics, Ltd., 21900 Burbank Boulevard 3rd. Floor, Woodland Hills, CA 91367, USA → ImmunoCellular Therapeutics, Ltd., 23622 Calabasas Road,, Suite 300, Calabasas, CA 91302, USA
Published in Swissreg on 06.07.2017
- Dec 7, 2016
Granted
Published in Swissreg on 07.12.2016
Parties
Inventor
SINGH, Manish
Woodland Hills, CA 91367, US
BENDER, James
Rancho Santa Margarita, CA 92688, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.